Literature DB >> 18226499

Pathology and pathophysiology of the amygdala in epileptogenesis and epilepsy.

Vassiliki Aroniadou-Anderjaska1, Brita Fritsch, Felicia Qashu, Maria F M Braga.   

Abstract

Acute brain insults, such as traumatic brain injury, status epilepticus, or stroke are common etiologies for the development of epilepsy, including temporal lobe epilepsy (TLE), which is often refractory to drug therapy. The mechanisms by which a brain injury can lead to epilepsy are poorly understood. It is well recognized that excessive glutamatergic activity plays a major role in the initial pathological and pathophysiological damage. This initial damage is followed by a latent period, during which there is no seizure activity, yet a number of pathophysiological and structural alterations are taking place in key brain regions, that culminate in the expression of epilepsy. The process by which affected/injured neurons that have survived the acute insult, along with well-preserved neurons are progressively forming hyperexcitable, epileptic neuronal networks has been termed epileptogenesis. Understanding the mechanisms of epileptogenesis is crucial for the development of therapeutic interventions that will prevent the manifestation of epilepsy after a brain injury, or reduce its severity. The amygdala, a temporal lobe structure that is most well known for its central role in emotional behavior, also plays a key role in epileptogenesis and epilepsy. In this article, we review the current knowledge on the pathology of the amygdala associated with epileptogenesis and/or epilepsy in TLE patients, and in animal models of TLE. In addition, because a derangement in the balance between glutamatergic and GABAergic synaptic transmission is a salient feature of hyperexcitable, epileptic neuronal circuits, we also review the information available on the role of the glutamatergic and GABAergic systems in epileptogenesis and epilepsy in the amygdala.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18226499      PMCID: PMC2272535          DOI: 10.1016/j.eplepsyres.2007.11.011

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  166 in total

Review 1.  Prevention and treatment of post-traumatic epilepsy.

Authors:  Carlo Alberto Pagni; Francesco Zenga
Journal:  Expert Rev Neurother       Date:  2006-08       Impact factor: 4.618

2.  Diffusion-weighted MR in experimental sustained seizures elicited with kainic acid.

Authors:  Y Nakasu; S Nakasu; S Morikawa; S Uemura; T Inubushi; J Handa
Journal:  AJNR Am J Neuroradiol       Date:  1995 Jun-Jul       Impact factor: 3.825

Review 3.  Genetics of the epilepsies.

Authors:  S F Berkovic; I E Scheffer
Journal:  Epilepsia       Date:  2001       Impact factor: 5.864

Review 4.  The role of the amygdala in emotional learning.

Authors:  M Davis
Journal:  Int Rev Neurobiol       Date:  1994       Impact factor: 3.230

Review 5.  Post traumatic epilepsy: a review of scientific evidence.

Authors:  Y K Gupta; Madhur Gupta
Journal:  Indian J Physiol Pharmacol       Date:  2006 Jan-Mar

6.  Amygdaloid sclerosis in temporal lobe epilepsy.

Authors:  L P Hudson; D G Munoz; L Miller; R S McLachlan; J P Girvin; W T Blume
Journal:  Ann Neurol       Date:  1993-06       Impact factor: 10.422

7.  Seizure control and extent of mesial temporal resection.

Authors:  R Jooma; H S Yeh; M D Privitera; D Rigrish; M Gartner
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

8.  Atrophy of mesial structures in patients with temporal lobe epilepsy: cause or consequence of repeated seizures?

Authors:  F Cendes; F Andermann; P Gloor; I Lopes-Cendes; E Andermann; D Melanson; M Jones-Gotman; Y Robitaille; A Evans; T Peters
Journal:  Ann Neurol       Date:  1993-12       Impact factor: 10.422

9.  Electrophysiologic changes in the lateral and basal amygdaloid nuclei in temporal lobe epilepsy: an in vitro study in epileptic rats.

Authors:  M Niittykoski; J Nissinen; M Penttonen; A Pitkänen
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

10.  Explicit and implicit facial affect recognition in manic and depressed States of bipolar disorder: a functional magnetic resonance imaging study.

Authors:  Chi-Hua Chen; Belinda Lennox; Rebecca Jacob; Andrew Calder; Vicky Lupson; Ruth Bisbrown-Chippendale; John Suckling; Ed Bullmore
Journal:  Biol Psychiatry       Date:  2005-08-22       Impact factor: 13.382

View more
  59 in total

1.  In vitro ictogenesis and parahippocampal networks in a rodent model of temporal lobe epilepsy.

Authors:  G Panuccio; M D'Antuono; P de Guzman; L De Lannoy; G Biagini; M Avoli
Journal:  Neurobiol Dis       Date:  2010-05-07       Impact factor: 5.996

Review 2.  Functional neuroanatomy of amygdalohippocampal interconnections and their role in learning and memory.

Authors:  Alexander J McDonald; David D Mott
Journal:  J Neurosci Res       Date:  2016-02-14       Impact factor: 4.164

3.  α7-Containing nicotinic acetylcholine receptors on interneurons of the basolateral amygdala and their role in the regulation of the network excitability.

Authors:  Volodymyr I Pidoplichko; Eric M Prager; Vassiliki Aroniadou-Anderjaska; Maria F M Braga
Journal:  J Neurophysiol       Date:  2013-09-04       Impact factor: 2.714

4.  Anandamide Signaling Augmentation Rescues Amygdala Synaptic Function and Comorbid Emotional Alterations in a Model of Epilepsy.

Authors:  Roberto Colangeli; Maria Morena; Quentin J Pittman; Matthew N Hill; G Campbell Teskey
Journal:  J Neurosci       Date:  2020-06-29       Impact factor: 6.167

5.  Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis.

Authors:  Brita Fritsch; Janine Reis; Maciej Gasior; Rafal M Kaminski; Michael A Rogawski
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

6.  Neuroprotective efficacy of caramiphen against soman and mechanisms of its action.

Authors:  T H Figueiredo; V Aroniadou-Anderjaska; F Qashu; J P Apland; V Pidoplichko; D Stevens; T M Ferrara; M F M Braga
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

7.  A rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonists.

Authors:  Steven L Miller; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Eric M Prager; Camila P Almeida-Suhett; James P Apland; Maria F M Braga
Journal:  Toxicol Appl Pharmacol       Date:  2015-02-15       Impact factor: 4.219

8.  The M1 Muscarinic Receptor Antagonist VU0255035 Delays the Development of Status Epilepticus after Organophosphate Exposure and Prevents Hyperexcitability in the Basolateral Amygdala.

Authors:  Steven L Miller; Vassiliki Aroniadou-Anderjaska; Volodymyr I Pidoplichko; Taiza H Figueiredo; James P Apland; Jishnu K S Krishnan; Maria F M Braga
Journal:  J Pharmacol Exp Ther       Date:  2016-10-31       Impact factor: 4.030

9.  Early MR diffusion and relaxation changes in the parahippocampal gyrus precede the onset of spontaneous seizures in an animal model of chronic limbic epilepsy.

Authors:  Mansi B Parekh; Paul R Carney; Hector Sepulveda; Wendy Norman; Michael King; Thomas H Mareci
Journal:  Exp Neurol       Date:  2010-04-13       Impact factor: 5.330

10.  Efficacy of the GluK1/AMPA receptor antagonist LY293558 against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration.

Authors:  James P Apland; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Carol E Green; Robert Swezey; Chun Yang; Felicia Qashu; Maria F M Braga
Journal:  J Pharmacol Exp Ther       Date:  2012-10-05       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.